Corbus Pharmaceuticals Holdings (CRBP) Operating Margin Growth (1y) (2016 - 2021)
Powered by 
Analysis
Corbus Pharmaceuticals Holdings (CRBP) Operating Margin Growth (1y) (2016 - 2021) Analysis & Trends
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Operating Margin Growth (1y) (Qtr) |
|---|---|---|---|---|---|
| 1 | Amgen | 206.44 Bn | 192.45 Bn | 7.24 Bn | 602.00 |
| 2 | Gilead Sciences | 179.97 Bn | 176.79 Bn | 6.22 Bn | -16,814.00 |
| 3 | Vertex Pharmaceuticals | 130.57 Bn | 122.72 Bn | 2.84 Bn | -143.00 |
| 4 | Regeneron Pharmaceuticals | 81.63 Bn | 73.63 Bn | 3.93 Bn | 78.00 |
| 5 | Argenx Se | 60.34 Bn | 55.16 Bn | 1.37 Bn | 1,135.00 |
| 6 | Moderna | 54.37 Bn | 49.23 Bn | 52.00 Mn | 7,666.00 |
| 7 | Alnylam Pharmaceuticals | 33.07 Bn | 29.76 Bn | 992.69 Mn | 2,002.00 |
| 8 | Biogen | 31.84 Bn | 30.55 Bn | 1.96 Bn | -2,881.00 |
| 9 | Roivant Sciences | 29.49 Bn | 29.49 Bn | 1.16 Mn | -1.23 Mn |
| 10 | Corbus Pharmaceuticals Holdings | 101.29 Mn | -61.98 Mn | - | - |
Historic Data
Download Data
Historic Data
| Date | Value |
|---|---|
| Sep 30, 2021 | -1.15 Mn |
| Jun 30, 2021 | 108,908.00 |
| Mar 31, 2021 | -68,334.00 |
| Dec 31, 2020 | -210,544.00 |
| Sep 30, 2020 | -179,165.00 |
| Jun 30, 2020 | -1.33 Mn |
| Mar 31, 2020 | -28,951.00 |
| Dec 31, 2019 | -14,382.00 |
| Sep 30, 2019 | 39,662.00 |
| Jun 30, 2019 | 145,772.00 |
| Mar 31, 2019 | -15,817.00 |
| Sep 30, 2018 | -49,206.00 |
| Jun 30, 2018 | 63,033.00 |
| Mar 31, 2018 | -67,230.00 |
| Sep 30, 2017 | -15,533.00 |
| Jun 30, 2017 | -102,530.00 |
| Mar 31, 2017 | 15,193.00 |
| Sep 30, 2016 | 60,460.00 |
| Jun 30, 2016 | 119,828.00 |